Aeolus Pharma Revenue, Profits - AOLS Quarterly Income Statement

Add to My Stocks
$0 $0 (0%) AOLS stock closing price Sep 19, 2018 (Closing)

Financial analysis of Aeolus Pharma involves more than just checking the Aeolus Pharma stock price, by looking at the financial statements of the company in detail. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the AOLS stock is bound to reflect the impact of the QOQ decline of 0. The operating expenses as shown in the Aeolus Pharma profit and loss statement for 2017 Q3 total to $0. This line item shows that the operating expenses has decreased compared with last year. Also check: Aeolus Pharma assets and Aeolus Pharma free cash flow.

View and download details of revenue and profits for Aeolus Pharma for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Aeolus Pharma Revenues or Net Sales
-------
Cost Of Goods Sold (COGS)-------
Aeolus Pharma Gross Profit
-------
Research & Development Expense-------
Selling General & Admin Expense-------
Income Before Depreciation Depletion Amortization-0.94M-1.03M-1.08M-1.04M-0.87M-0.62M-0.74M
Depreciation Depletion Amortization-------
Non Operating Income-------
Interest Expense-------
Aeolus Pharma Pretax Income
-0.94M-1.03M-1.08M-1.03M-0.87M-0.62M-1.03M
Provision for Income Taxes-------
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-0.95M-1.04M-1.09M-1.02M-0.87M-0.63M-1.03M
Extraordinary Items & Discontinued Operations-------
Aeolus Pharma Profit/ Loss (Net Income)
-0.95M-1.04M-1.09M-1.02M-0.87M-0.63M-1.03M
Average Shares used to compute Diluted EPS152.09M152.09M152.09M154.57M151.65M151.56M139.44M
Average Shares used to compute Basic EPS152.09M152.09M152.09M154.57M151.65M151.56M139.44M
Income Before Nonrecurring Items-0.95M-1.04M-1.09M-1.02M-0.87M-0.63M-1.03M
Income from Nonrecurring Items-------
Aeolus Pharma Earnings Per Share Basic Net
-0.01-0.01-0.01-0.01-0.01-0.02-0.01
Aeolus Pharma Earnings Per Share Diluted Net
-0.01-0.01-0.01-0.01-0.01-0.02-0.01
EPS Diluted Before Nonrecurring Items-0.01-0.01-0.01-0.01-0.01-0.02-0.01
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Aeolus Pharma stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Aeolus Pharma revenue chart, implies that the company is growing. It has not been the case with Aeolus Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-0.95M for Aeolus Pharma for 2017 Q3. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The AOLS financials along with Aeolus Pharma historical stock prices provide a lot of details about the firm.

Aeolus Pharma Income Statement - Key Financial Ratios

Other Income Statements - Aeolus Pharmaceuticals, Inc. Industry Peers

Cleveland BioLabs income statement, Respirerx Pharma income statement, Titan Pharma income statement